The Naval Medical Logistics Command has a requirement for one (1) laser, excimer [17-161] for Naval Medical Center San Diego (NMCSD). The excimer laser equipment shall be cleared by the Food & Drug Administration (FDA) to treat mild-to-moderate psoriasis and vitiligo. The excimer laser equipment shall utilize a monochromatic, high intensity ultraviolet B (UVB) xenon chloride (XeCl) laser at the specific wavelength of 308 nm to treat the affected skin areas. The excimer laser equipment shall be non-thermal and non-ablative. The solution shall include a hand piece with a continuously adjustable spot size, from a large square to a small circle, with an upper range of at least 3 cm2 and aiming beam to accurately target the diseased tissue and to protect the surrounding healthy skin from exposure. Additionally, the hand piece should be designed with a handle for ease-of-use for the NMCSD personnel.

The solution shall include the following excimer laser accessories: one (1) XeCl gas cylinder, fiber optic cable, a set of two (2) optical mirrors, ten (10) standard and two (2) linear treatment tips, three (3) pairs of laser goggles, and two (2) laser keys. The requirement shall include two (2) operator manuals and two (2) service manuals. The power requirements are 120 VAC, 50-60 Hz.

Vendor shall be an Original Equipment Manufacturer (OEM) authorized dealer, authorized distributor or authorized reseller for the proposed equipment/system, such that OEM warranty and service are provided and maintained by the OEM. All software licensing, warranty and service associated with the equipment/system shall be in accordance with the OEM terms and conditions.

Upon delivery, the vendor shall be responsible for uncrating the unit/system, transporting it through the facility to the location of intended use for installation, and removing all trash created in this process. If interim storage is required, the vendor shall make arrangements for the storage.

The system, including claims made for the product, shall be compliant with Food and Drug Administration (FDA) regulations, with respect to marketing and delivering medical products for use in the United States of America. These requirements shall apply even if delivery is requested outside of the United States of America. The system shall be installed in compliance with OSHA requirements.

There are not set-aside restrictions for this requirement. The intended procurement will be classified under North America Industry Classification System (NAICS) 334510. This notice of intent is not a request for competitive proposals and no solicitation document exists for this requirement. However, parties interested in responding to this notice will need to submit technical data sufficient to determine capability in providing the same product. All capability statements received by the closing date of this synopsis will be considered by the Government. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement.
If a vendor challenges the basis of this requirement, please email product capability statements (formats for submission: PDF, MS Word, or MS Excel) to Derek Bell at [email protected]. Closing date for challenges is no later than 3:00 PM ET on 13 December 2018. No phone calls will be accepted.